TrialSignal
Clinical trial intelligence report
A Pilot Randomized Controlled Trial of A Comprehensive Cognitive and Affective Intervention for Neurocognitive Disorders (CoINTEGRATE)
Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.
Generated
Jun 20, 2026
NCT ID
NCT05732285
Status
COMPLETED
Phase
NA
Sponsor
University of Michigan
Executive brief
Investment-Ready Snapshot
A Pilot Randomized Controlled Trial of A Comprehensive Cognitive and Affective Intervention for Neurocognitive Disorders (CoINTEGRATE) is a NA clinical asset sponsored by University of Michigan in Neurocognitive Disorders, Cognitive Dysfunction, Traumatic Brain Injury, Multiple Sclerosis, Mild Cognitive Impairment. SEO and diligence focus: CRT, CBT, Modifiable lifestyle factors, Usual care Psychoeducation, endpoint relevance, enrollment feasibility, competitive positioning, readout timing and IP durability.
Source & freshness
Provenance
https://clinicaltrials.gov/study/NCT05732285
Indication
Neurocognitive Disorders
Modality
behavioral intervention
Target
CRT, CBT, Modifiable lifestyle factors, Usual care Psychoeducation
Intervention
CRT, CBT, Modifiable lifestyle factors, Usual care Psychoeducation
Source record
Protocol Description
Detailed source ingestion pending.
Source record
Outcome Measures
Detailed source ingestion pending.
Source record
Eligibility
Detailed source ingestion pending.
AI analysis
Known Results And Readout Context
Detailed source ingestion pending.
IP intelligence
Patent And IP Landscape
Detailed source ingestion pending.
Source record
Contacts
Detailed source ingestion pending.